Disease management
Joyful Health secured $17 million for AI revenue cycle management offering, and Osteoboost Health closed an $8 million round for its wearable osteopenia device.
The company will use the funds to expand its commercial operations, grow its workforce, and scale its platform and infrastructure.
The database will be created in partnership with the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at the Virginia Commonwealth University School of Medicine.
Sky Labs has introduced a BP ring for inpatients, helping reduce manual checks and improve data capture, as hospitals look to ease nursing workload.
The AI decision-support system, trained on multimodal ophthalmic data, will assist in diagnosis, treatment planning, and disease monitoring and management.
It will be based on an AI model that achieved high accuracy in predicting liver metastasis using patients' routine blood tests.
Also, Zydus has introduced two AI-enabled CGM devices in India.
Chinese regulators have cleared a device that helps patients with severe paralysis restore hand movement.
A new big data-based predictive model developed in Hong Kong enables more dynamic monitoring of six common cardiovascular diseases by capturing near-real-time biological changes.
The new alliance adds to b.well's partnerships with OpenAI, Google and Samsung to unify and personalize AI-driven health answers using individuals' medical data.